ArticleScientific reports2020

Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease.

Rebecca Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.